Risk Factors and Characteristics of Candidemia After Cardiac Surgery in Pediatric Patients in Central Israel

Pediatr Infect Dis J. 2023 May 1;42(5):368-373. doi: 10.1097/INF.0000000000003847. Epub 2023 Feb 20.

Abstract

Background: Candidemia is a serious complication in pediatric patients with congenital heart defects (CHD) after cardiac surgery. Information about the epidemiology, clinical characteristics and risk factors for candidemia in this vulnerable population remains limited.

Methods: This retrospective case-control study was conducted in 2 pediatric intensive care units between 2004 and 2019. All patients <18 years old who developed candidemia following cardiac surgery were included. Each case was matched with 2 control patients based on age and date of surgery. Multivariable logistic regression analysis was conducted to determine the risk factors for postoperative candidemia.

Results: Thirty-five candidemia cases were identified and matched to 70 control cases. The incidence of candidemia was 6.3 episodes per 1000 admissions. The median age for candidemia cases was 4 months. The attributable mortality was 28.5%. The predominant (54%) pathogens isolated were non- albicans Candida species, of which C. parapsilosis isolates demonstrated high resistance to fluconazole (70%). Independent risk factors associated with candidemia included cumulative antibiotic exposure for ≥4 days [OR: -4.3; 95% confidence interval (CI): 1.3-14.6; P = 0.02], the need for total parenteral nutrition or peritoneal dialysis (OR: -6.1; 95% CI: 2-18.8; P = 0.001), male sex (OR: 6.2; 95% CI: 1.9-20.3; P = 0.002) and delayed sternal closure≥2 days (OR: -3.2; 95% CI: 1-11.2; P = 0.05).

Conclusions: Postoperative candidemia in children with CHD is an uncommon but severe complication. Our study revealed an unexpectedly high frequency of fluconazole-resistant C. parapsilosis as the main cause of non- albicans candidemia. In addition to confirming previously recognized risk factors, our results reveal new potential risk factors such as delayed sternal closure and male sex.

MeSH terms

  • Adolescent
  • Antifungal Agents / therapeutic use
  • Candida parapsilosis
  • Candidemia* / drug therapy
  • Cardiac Surgical Procedures* / adverse effects
  • Case-Control Studies
  • Child
  • Fluconazole / therapeutic use
  • Humans
  • Infant
  • Israel / epidemiology
  • Male
  • Retrospective Studies
  • Risk Factors

Substances

  • Fluconazole
  • Antifungal Agents